Genetic aberrations in GBM, including EGFR, PDGFRA, PTEN, TP53, and PIK3CA, drive the dysfunction of signalling pathways, including PI3K/Akt/mTOR, p53, and Rb1 (34). This evidence concerns the gene AKT1 and glioblastoma.